Pneumococcal vaccine for adults and at risk (2025)

Concepts

• vaccines
• risk groups
• pneumococcal vaccine
• adults
• pneumococcal
• vaccine
• the legitimate commercial interest
• the public contracts regulations
• the supplier
• an additional 24 months

Location

United Kingdom: Lutterworth, UK

Description

Provision of pneumococcal vaccine for adults and at risk groups (2025)

Total Quantity or Scope

A contract for the supply of pneumococcal vaccine for adults and at risk groups (2025).Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Award Detail

Renewal Options

The contract has the option to be extended for up to an additional 24 months

Award Criteria

CPV Codes

• 33651600 - Vaccines

Indicators

• Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The contract is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.